KRAS and neoplasm: Frequently, mutations in the KRAS gene occur concomitantly with mutations in the GNAS gene in the RAP1 signaling pathway, which involves numerous biological processes, including invasiveness, adhesion, cell migration and polarization, and tumor metastasis.